Abstract:Background Parkinson's disease (PD) is a prevailing neurodegenerative disorder increasingly affecting the elderly population. The involvement of microRNAs (miRNAs) in PD has been confirmed. We sought to explore the molecular mechanism of miR‐20a‐5p in PD. Methods Lipopolysaccharide (LPS)‐induced BV2 cell model and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine hydrochloride (MPTP‐HCl)‐induced PD mouse model were established. miR‐20a‐5p, inducible nitric oxide synthase (iNOS), interleukin (IL)‐6, tumour necrosis factor (TNF)‐α, transforming growth factor (TGF)‐β1, and IL‐10 expression in BV2 cells was examined by reverse transcription – quantitative polymerase chain reaction. Cell viability was assessed by MTT assay. The apoptotic rate and levels of Bcl‐2, Bax, cleaved caspase‐3, and signal transducer and activator of transmission (STAT)3 were examined by flow cytometry and Western blot. Bioinformatics software predicted the potential binding sites of miR‐20a‐5p and STAT3. Dual‐luciferase experiment verified the binding relationship. Iba1‐positive and tyrosine hydroxylase (TH)‐positive cell numbers in substantia nigra pars compacta were detected by immunohistochemistry. The effect of miR‐20a‐5p on motor function in MPTP‐induced PD mice was detected by Rota‐rod test, Pole test, Traction test and Beam‐crossing task. Results miR‐20a‐5p was under‐expressed in LPS‐induced BV2 cells. Overexpression of miR‐20a‐5p increased the viability of LPS‐induced BV2 cells and reduced apoptosis rates. Moreover, overexpression of miR‐20a‐5p reduced cleaved caspase‐3, Bax, iNOS, IL‐6, and TNF‐α and increased Bcl‐2 and TGF‐β1, and IL‐10. miR‐20a‐5p targeted STAT3. STAT3 overexpression partially reversed miR‐20a‐5p overexpression‐mediated effects on LPS‐induced BV2 cell viability, apoptosis, and inflammatory responses. miR‐20a‐5p overexpression inhibited MPTP‐induced STAT3 and α‐synuclein levels, microglia activation, and inflammatory response, and reduced the loss of TH‐positive cells in mice. miR‐20a‐5p overexpression ameliorated MPTP‐induced dyskinesia in PD model mice. Conclusion miR‐20a‐5p alleviates neuronal damage and suppresses inflammation by targeting STAT3 in PD.

The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease

Dopaminergic Neuron Injury in Parkinson Disease is Mitigated by Interfering Lncrna SNHG14 Expression to Regulate the Mir-133B/α-synuclein Pathway

SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease

Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson’s disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein

Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1‐methyl‐4‐phenylpyridinium ion‐induced cytotoxicity and reactive oxygen species production through miR‐15b‐5p/GSK3β axis in human dopaminergic SH‐SY5Y cells

LncRNA SNHG1 promotes neuronal injury in Parkinson’s disease cell model by miR-181a-5p/CXCL12 axis

HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson’s disease by elevating NPTX2 via miR-221-3p binding

SNHG14 Upregulation Was a Molecular Mechanism Underlying MPP+ Neurotoxicity in Dopaminergic SK-N-SH Cells via SNHG14-miR-519a-3p-ATG10 ceRNA Pathway

Knockdown of SNHG14 Alleviates MPP+-Induced Injury in the Cell Model of Parkinson’s Disease by Targeting the miR-214-3p/KLF4 Axis

Identification of Critical Genes and miRNAs Associated with the Development of Parkinson’s Disease

Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson’s Disease Via Regulating Mir-7/Nlrp3 Pathway

High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model

Long Noncoding RNA SRY-box Transcription Factor 2 Overlapping Transcript Participates in Parkinson's Disease by Regulating the Microrna-942-5p/nuclear Apoptosis-Inducing Factor 1 Axis.

Lncrna NEAT1 Promotes Autophagy of Neurons in Mice by Impairing Mir-107-5p.

Suppression Of Microrna-342-3p Increases Glutamate Transporters And Prevents Dopaminergic Neuron Loss Through Activating The Wnt Signaling Pathway Via P21-Activated Kinase 1 In Mice With Parkinson'S Disease

Subcellular localization and function analysis of PINK1 mitron in PD progression: Mitron modulates mitochondrial morphology to regulate neuronal death

Retracted: Suppression of Microrna‐342‐3p Increases Glutamate Transporters and Prevents Dopaminergic Neuron Loss Through Activating the Wnt Signaling Pathway Via P21‐activated Kinase 1 in Mice with Parkinson's Disease

MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson’s disease

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model

LncRNA Mir-17-92a-1 Cluster Host Gene (MIR17HG) Promotes Neuronal Damage and Microglial Activation by Targeting the Microrna-153-3p/alpha-synuclein Axis in Parkinson’s Disease

Regulatory mechanism of miR‐20a‐5p in neuronal damage and inflammation in lipopolysaccharide‐induced BV2 cells and MPTP‐HCl‐induced Parkinson's disease mice